CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory-Reference-Cited by-同舟云学术

CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory

Published:2018-10-31 Issue:2 Volume:18 Page:312-322
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Benonisson Hreinn^ORCID,Altıntaş Işıl,Sluijter Marjolein,Verploegen Sandra,Labrijn Aran F.,Schuurhuis Danita H.,Houtkamp Mischa A.,Verbeek J. Sjef,Schuurman Janine^ORCID,van Hall Thorbald^ORCID

Funder

European Union's Seventh Framework Programme

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy;Nature Communications;2024-08-23

2. IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer;International Immunopharmacology;2024-08

3. Oral administration of IPI549 protects mice from neuropathology and an overwhelming inflammatory response during experimental cerebral malaria;International Journal for Parasitology: Drugs and Drug Resistance;2024-08

4. Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory;Virologica Sinica;2024-06

5. Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy;Cancer Cell;2024-06